Paul Saladino: There's a concept of residual risk, right? We take someone with high LDL and they've got all these other stuff. They've got high triglycerides. They'veGot high inflammation, right? LDL comes in all of the interventions that we have. The target still is LDL coming down first; then you've got residual risk if someone still has high triglycerides because their LDL is low. And so what you saw in that trial was that in patients who achieved neither getting their LDL under 70 milligrams or getting CRP under two milligrams per liter, they didn't really have much of a risk reduction. But at that point, those individuals will benefit from

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode